BioSpace News Archive

Wesana Health Holdings Inc. has announced its fourth quarter and full-year 2021 financial results.

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported first quarter 2022 financial results and provided a corporate update.

The sessions may be accessed from the “Investors & Media” page of Regeneron’s website.

Umoja Biopharma, Inc. announced that it will have an oral presentation and two posters at the American Society of Gene and Cell Therapy 25th Annual Meeting, to be held May 16-19, 2022.

Genenta Science announces that preliminary findings from its Phase 1/2a of Temferon™ in the treatment of patients with glioblastoma multiforme patients who have an unmethylated MGMT gene promoter provide initial evidence of Temferon’s potential for modulating the tumor microenvironment as well as details of Temferon’s continuing positive safety profile and signals of biological activity.

Adverum Biotechnologies, Inc. announced new data will be presented during the American Society of Gene & Cell Therapy 2022 Annual Meeting, being held May 16-19, 2022, in Washington D.C. and virtually.

Johnson & Johnson will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1st, at the New York Hilton Midtown in New York.

Stoke Therapeutics, Inc. (Nasdaq: STOK), today announced new preclinical data that demonstrated dose-related target engagement and increases in OPA1 protein levels in retinal tissue of non-human primates (NHPs) following intravitreal (IVT) administration of STK-002.

American Skin Association has announced the names of the two awardees receiving the coveted research grant under the ASA Milstein Research Scholar Awards program.

OSE Immunotherapeutics SA announced the grant of a new patent from the European Patent Office strengthening the protection covering its novel myeloid cell immune checkpoint target, CLEC-1, and its use in cancer treatment.